A Randomized Controlled Trial of InterVapor® in France - the TARGET Trial
Not Applicable
Terminated
- Conditions
- Emphysema
- Interventions
- Device: Treatment plus Optimal Medical TherapyOther: Optimal Medical Therapy
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Uptake Medical Technology, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT05118269
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Toulouse, Toulouse, France
A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)
Not Applicable
Completed
- Conditions
- Emphysema or COPD
- Interventions
- Device: Bronchoscopic Thermal Vapor Ablation (BTVA)
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Uptake Medical Technology, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT03670121
- Locations
- 🇩🇪
Thoraxklinik University of Heidelberg, Heidelberg, Germany
Vapor Ablation for Localized Cancer Lesions
Not Applicable
Not yet recruiting
- Conditions
- Metastatic Lung CancerLung CancerNon Small Cell Lung Cancer
- Interventions
- Device: Bronchoscopic Thermal Vapor Ablation
- First Posted Date
- 2018-05-02
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Uptake Medical Technology, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03514329
- Locations
- 🇦🇹
Otto-Wagner Hospital, Vienna, Austria
🇮🇹Azienda Ospedaliero - Universitaria, Ancona, Italy
Post-Market BTVA Registry
Recruiting
- Conditions
- Emphysema or COPD
- Interventions
- Device: Bronchoscopic Thermal Vapor Ablation
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Uptake Medical Technology, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT03318406
- Locations
- 🇦🇹
Krankenhaus Nord - Klinik Floridsdorf, Vienna, Austria
🇩🇪Sozialstiftung Bamberg, Klinikum am Bruderwald, Bamberg, Germany
🇩🇪DRK Kliniken Berlin / Mitte, Berlin, Germany
Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)
Not Applicable
Completed
- Conditions
- Non Small Cell Lung CancerMetastatic Lung CancerLung Cancer
- Interventions
- Device: Bronchoscopic Thermal Vapor Ablation
- First Posted Date
- 2017-06-26
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Uptake Medical Technology, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03198468
- Locations
- 🇦🇺
The Royal Melbourne Hospital, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath